Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term

[1]  Heidi Moawad.  Identifying Prodromal Parkinson Disease , 2018 .

[2]  D. Wesson,et al.  The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases , 2016, Neurobiology of Disease.

[3]  C. Zurzolo,et al.  α-Synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading , 2017, Acta Neuropathologica.

[4]  K. Luk,et al.  Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production , 2017, Cellular and Molecular Life Sciences.

[5]  T. Montine,et al.  Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis , 2017, The Lancet Neurology.

[6]  M. Diamond,et al.  Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo , 2016, Neuron.

[7]  Jacob I. Ayers,et al.  Robust Central Nervous System Pathology in Transgenic Mice following Peripheral Injection of α-Synuclein Fibrils , 2016, Journal of Virology.

[8]  John Q Trojanowski,et al.  Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson’s disease , 2016, The Journal of experimental medicine.

[9]  N. Tanık,et al.  Associations of olfactory bulb and depth of olfactory sulcus with basal ganglia and hippocampus in patients with Parkinson’s disease , 2016, Neuroscience Letters.

[10]  Abid Oueslati.  Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade? , 2016, Journal of Parkinson's disease.

[11]  P. Brundin,et al.  Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion‐like behaviour of alpha‐synuclein , 2016, Neuropathology and applied neurobiology.

[12]  H. Braak,et al.  Review: Sporadic Parkinson's disease: development and distribution of α‐synuclein pathology , 2016, Neuropathology and applied neurobiology.

[13]  G. Halliday,et al.  Neuropathology of α‐synuclein propagation and braak hypothesis , 2016, Movement disorders : official journal of the Movement Disorder Society.

[14]  E. Bézard,et al.  Alpha‐synuclein propagation: New insights from animal models , 2016, Movement disorders : official journal of the Movement Disorder Society.

[15]  G. Wenning,et al.  Glia and alpha-synuclein in neurodegeneration: A complex interaction , 2016, Neurobiology of Disease.

[16]  J. Trojanowski,et al.  Pathological α-synuclein distribution in subjects with coincident Alzheimer’s and Lewy body pathology , 2016, Acta Neuropathologica.

[17]  Jennifer Luebke,et al.  Depletion of microglia and inhibition of exosome synthesis halt tau propagation , 2015, Nature Neuroscience.

[18]  Elliott W. Dirr,et al.  Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration , 2015, Neurobiology of Disease.

[19]  M. Romero-Ramos,et al.  The relation between α-synuclein and microglia in Parkinson’s disease: Recent developments , 2015, Neuroscience.

[20]  M. Giugliano,et al.  α-Synuclein strains cause distinct synucleinopathies after local and systemic administration , 2015, Nature.

[21]  A. Rana,et al.  Parkinson’s disease: a review of non-motor symptoms , 2015, Expert review of neurotherapeutics.

[22]  P. Brundin,et al.  Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: A speculative synthesis , 2015, Neurobiology of Disease.

[23]  Gusel'nikova Vv,et al.  NeuN As a Neuronal Nuclear Antigen and Neuron Differentiation Marker. , 2015 .

[24]  Vivek K Unni,et al.  Progressive aggregation of alpha-synuclein and selective degeneration of Lewy inclusion-bearing neurons in a mouse model of parkinsonism , 2015, Cell reports.

[25]  V. Gusel’nikova,et al.  NeuN As a Neuronal Nuclear Antigen and Neuron Differentiation Marker , 2015 .

[26]  T. Golde,et al.  Brain Injection of α-Synuclein Induces Multiple Proteinopathies, Gliosis, and a Neuronal Injury Marker , 2014, The Journal of Neuroscience.

[27]  K. Luk,et al.  Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite–like aggregates , 2014, Nature Protocols.

[28]  Suzana Herculano-Houzel,et al.  The glia/neuron ratio: How it varies uniformly across brain structures and species and what that means for brain physiology and evolution , 2014, Glia.

[29]  H. Akiyama,et al.  Pathological alpha-synuclein propagates through neural networks , 2014, Acta neuropathologica communications.

[30]  Jacob I. Ayers,et al.  Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice , 2014, Proceedings of the National Academy of Sciences.

[31]  Murray Grossman,et al.  A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank , 2014, Alzheimer's & Dementia.

[32]  E. Sukhorukova.  Nuclear Protein NeuN in Neurons in the Human Substantia Nigra , 2014, Neuroscience and Behavioral Physiology.

[33]  P. Brunjes,et al.  Diversity among principal and GABAergic neurons of the anterior olfactory nucleus , 2014, Front. Cell. Neurosci..

[34]  T. Golde,et al.  Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice , 2014, Acta Neuropathologica.

[35]  E. Bézard,et al.  Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys , 2014, Annals of neurology.

[36]  Y. Sohn,et al.  Olfactory performance acts as a cognitive reserve in non-demented patients with Parkinson's disease. , 2014, Parkinsonism & related disorders.

[37]  V. Lee,et al.  Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases , 2014, Nature Medicine.

[38]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[39]  P. Brundin,et al.  Transfer of human α-synuclein from the olfactory bulb to interconnected brain regions in mice , 2013, Acta Neuropathologica.

[40]  T. Golde,et al.  Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein , 2013, Acta neuropathologica communications.

[41]  John M. Bekkers,et al.  Neurons and circuits for odor processing in the piriform cortex , 2013, Trends in Neurosciences.

[42]  A. Lavezzi,et al.  Neuronal nuclear antigen (NeuN): A useful marker of neuronal immaturity in sudden unexplained perinatal death , 2013, Journal of the Neurological Sciences.

[43]  P. Brundin,et al.  α‐Synuclein: The Long Distance Runner , 2013, Brain pathology.

[44]  Masato Hasegawa,et al.  Prion-like spreading of pathological α-synuclein in brain , 2013, Brain : a journal of neurology.

[45]  M. Xilouri,et al.  Alpha-synuclein and Protein Degradation Systems: a Reciprocal Relationship , 2012, Molecular Neurobiology.

[46]  J. Trojanowski,et al.  Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice , 2012, Science.

[47]  E. Morignat,et al.  Prion-like acceleration of a synucleinopathy in a transgenic mouse model , 2012, Neurobiology of Aging.

[48]  J. Trojanowski,et al.  Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice , 2012, The Journal of experimental medicine.

[49]  W. Oertel,et al.  Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[50]  J. Trojanowski,et al.  α-Syn Suppression Reverses Synaptic and Memory Defects in a Mouse Model of Dementia with Lewy Bodies , 2011, The Journal of Neuroscience.

[51]  Ws. Rasband.  ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA , 2011 .

[52]  K. Fiedler,et al.  Olfactory Impairment Predicts Brain Atrophy in Parkinson's Disease , 2009, The Journal of Neuroscience.

[53]  S. Prusiner,et al.  Is Parkinson's disease a prion disorder? , 2009, Proceedings of the National Academy of Sciences.

[54]  H. Shill,et al.  Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction , 2009, Acta Neuropathologica.

[55]  J. Trojanowski,et al.  Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies , 2009, Acta Neuropathologica.

[56]  John L. Robinson,et al.  Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases , 2007, Acta Neuropathologica.

[57]  E. Lai,et al.  Non-motor Symptoms of Parkinson's Disease , 2007 .

[58]  Peter C. Brunjes,et al.  A field guide to the anterior olfactory nucleus (cortex) , 2005, Brain Research Reviews.

[59]  Mark R Cookson,et al.  The biochemistry of Parkinson's disease. , 2005, Annual review of biochemistry.

[60]  Belinda Wilson,et al.  Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[61]  Lili Tian,et al.  A Comparison of the General Linear Mixed Model and Repeated Measures ANOVA Using a Dataset with Multiple Missing Data Points , 2004, Biological research for nursing.

[62]  Hansjürgen Bratzke,et al.  Stages in the development of Parkinson’s disease-related pathology , 2004, Cell and Tissue Research.

[63]  R. Vertes.  Differential projections of the infralimbic and prelimbic cortex in the rat , 2004, Synapse.

[64]  S. Goldman,et al.  New roles for astrocytes: Redefining the functional architecture of the brain , 2003, Trends in Neurosciences.

[65]  H. Braak,et al.  Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen , 2003, Journal of Neural Transmission.

[66]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[67]  G. Halliday,et al.  Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. , 2002, Brain : a journal of neurology.

[68]  E. Masliah,et al.  α-Synuclein is phosphorylated in synucleinopathy lesions , 2002, Nature Cell Biology.

[69]  E. Masliah,et al.  alpha-Synuclein is phosphorylated in synucleinopathy lesions. , 2002, Nature cell biology.

[70]  J. Y. Lee,et al.  Age-related change of neuropeptide Y-immunoreactive neurons in the rat anterior olfactory nucleus , 2001, Journal of neurocytology.

[71]  Michel Goedert,et al.  Alpha-synuclein and neurodegenerative diseases , 2001, Nature Reviews Neuroscience.

[72]  G. Irvine,et al.  Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins. , 2000, Journal of structural biology.

[73]  Harvey B Sarnat,et al.  Neuronal nuclear antigen (NeuN): a marker of neuronal maturation in the early human fetal nervous system 1 Presented at the XIII International Congress of Neuropathology, Perth, Australia, September 7–12, 1997. 1 , 1998, Brain and Development.

[74]  T Pietsch,et al.  NeuN: a useful neuronal marker for diagnostic histopathology. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[75]  S. Daniel,et al.  The anterior olfactory nucleus in Parkinson's disease , 1995, Movement disorders : official journal of the Movement Disorder Society.

[76]  E. Vanmechelen,et al.  Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205 , 1995, Neuroscience Letters.

[77]  Wade K. Smith,et al.  Disease‐specific patterns of locus coeruleus cell loss , 1992, Annals of neurology.

[78]  R. J. Mullen,et al.  NeuN, a neuronal specific nuclear protein in vertebrates. , 1992, Development.

[79]  S. Bayer,et al.  Neurogenesis in the anterior olfactory nucleus and its associated transition areas in the rat brain , 1986, International Journal of Developmental Neuroscience.